7Baggers
 sol-gel technologies announces 2025 annual general meeting  The Globe and Mail Fri, 26 Sep 2025 18:30:00 GMT
 Sol-Gel Technologies Leads Market with 400.72% Return Over Six Months  Markets Mojo Fri, 26 Sep 2025 11:19:32 GMT
 sol-gel technologies schedules annual shareholder meeting for november 11  Investing.com Canada Fri, 26 Sep 2025 04:37:44 GMT
 sol-gel technologies hits new 52-week high of $30.98, surges 3861%  Markets Mojo Thu, 25 Sep 2025 19:28:37 GMT
 Sol-Gel Technologies Announces 2025 Annual General Meeting  TipRanks Thu, 25 Sep 2025 18:28:33 GMT
 Sol-Gel Technologies Leads Six-Month Stock Returns with 387.38% Gain  Markets Mojo Thu, 25 Sep 2025 12:05:30 GMT
 sol-gel technologies hits new 52-week high of $30.98, surges 3861%  Markets Mojo Wed, 24 Sep 2025 02:04:25 GMT
 Sol-Gel announces Health Canada approval of EPSOLAY  MSN Sat, 20 Sep 2025 05:16:18 GMT
 Sol-Gel Announces Health Canada Approval of EPSOLAY®  Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
 Sol-Gel Technologies Secures Health Canada Approval for EPSOLAY  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 Health Canada approves Sol-Gel’s rosacea treatment EPSOLAY  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 08:12:42  Newser Sun, 31 Aug 2025 13:12:42 GMT
 sol-gel technologies reports strong q2 2025 results  MSN Fri, 29 Aug 2025 18:42:38 GMT
 sol gel technologies trading halted amid volatility  AInvest Sun, 24 Aug 2025 07:00:00 GMT

Sol-Gel Technologies Ltd
(NASDAQ:SLGL) 

SLGL stock logo

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-dail...

Founded: 1997
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends